Drug Assessment Reports
LAST ISSUES
NILEMDO® / NUSTENDI®: Prodrug that inhibits adenosine triphosphate citrate lyase by reducing intracellular cholesterol, increasing the number of LDL receptors on the cell surface, decreasing plasma LDL cholesterol (LDL-c) concentration.
NILEMDO® / NUSTENDI®: Profármaco que inhibe la adenosina trifosfato citrato liasa reduciendo el colesterol intracelular, lo que aumenta el número de receptores de LDL en la superficie celular, disminuyendo la concentración plasmática de C-LDL.
JARDIANCE®: Treatment of symptomatic, chronic heart failure (HF) with reduced (HFrEF, EF≤40%), mildly-reduced (HFmrEF, EF 41-49%) and preserved (HFpEF, EF>50%) ejection fraction. In Spain, it is funded for HFrEF patients with increased NT-proBNP levels and not controlled with recommended first-line therapies (ACE inhibitors or ARBs or sacubitril/valsartan with beta-blocker and mineralocorticoid receptor antagonist; unless intolerance or contraindication), as well as in symptomatic HFpEF with increased NT-proBNP levels. It is also labeled for the treatment of type 2 diabetes mellitus.
2024
-
Nilemdo® / Nustendi®. Bempedoic Acid and Bempedoic Acid/Ezetimibe for hipercholesterolaemia
2023
-
Jardiance®. Empagliflozin for symptomatic, chronic heart failure
-
Verquvo®. Vericiguat in heart failure
-
Forxiga® / Edistride®. Dapagliflozin in chronic kidney disease
-
Evenity®. Romosozumab for osteoporosis
2022
-
Forxiga® /Edistride®.Dapagliflozin for heart failure with reduced ejection fraction (HFrEF)
-
Rizmoic®. Naldemedine for opioid-induced constipation
-
Todacitan®. Citisine for smoking cessation
- Rybelsus®. Oral semaglutid for type 2 diabetes mellitus
2020
2019
- Skilarence®. Dimethyl fumarate for psoriasis
2018
- Trimbow®. Beclomethasone / Formoterol / Glycopyrronium bromide for COPD
- Mictonorm®. Propiverine for urinary incontinence
2017
- Conjugated Oestrogens / Bazedoxifene. Duavive® for the symptoms of menopause
- GuanfacinE. Intuniv® for the treatment of attention déficit hyperactivity disorder (ADHD)
- Naloxegol. Moventig® for opioid-induced constipation
- Brivaracetam. Briviact® for epylepsia (partial-onset seizures)
- Sacubitril/Valsartan. Entresto-Neparvis® for heart failure
- Olodaterol/Tiotropium. Spiolto Respimat®, Yanimo Respimat® for COPD
COVID-19 (content only in spanish)
Informes de actualidad farmacoterapéutica
2022
2021-Vacunas
- Vacuna JANSSEN 31-03-2021
- Vacuna Covid-19 ChAdOx1 ASTRAZENECA / Universidad de Oxford 03-02-2021
- Vacuna ARNm Covid-19 MODERNA 29-01-2021
- Vacuna ARNm Covid-19 (Comirnaty®) PFIZER / BioNTech 29-01-2021
2020
- REMDESIVIR 15-12-2020